Xcout Intel
Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Subscribe to see Axonis Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Axonis Therapeutics, Inc. at a glance
Axonis Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $125M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $120M in October 2024. Xcout tracks 13 named people at Axonis Therapeutics, Inc., including JEFF IMBARO (Chief Operating Officer).
Axonis Therapeutics, Inc. leadership
- JEFF IMBAROChief Operating Officer
- Jeffrey ImbaroChief Operating Officer
- Joanna StanickaCEO, President & Co-Founder
- SHANE V. HEGARTYChief Scientific Officer & Co-Founder
- Donald J. Manning, M.D., Ph.DExecutive Officer
- Donald Manning, M.D., Ph.DExecutive Officer
7 more named people on record for Axonis Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Axonis Therapeutics, Inc. funding rounds
At least $125M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $120M | 14 named | |
| Series A | $5M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Axonis Therapeutics, Inc. competitors
A few of Axonis Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company founded in 2011 and headquartered in Boston, Massachusetts. The company focuses on developing novel treatments for devastating neurological conditions.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Atalanta Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, focused on developing RNA-interference therapeutic interventions for neurodegenerative diseases. The company launched with significant venture backing from life sciences investors.
AstronauTx is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2019, the firm develops novel small-molecule drugs aimed at treating neurodegenerative conditions such as Alzheimer's disease by targeting glial cell dysfunction.
Solvonis Therapeutics plc is a biopharmaceutical company that develops novel medicines for central nervous system (CNS) disorders. Its initial therapeutic focus is on treating Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with discovery programs extending into broader addiction, psychiatry, and neurology fields.
Get Axonis Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Axonis Therapeutics, Inc. in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access